[1] |
MA Yifei , LIANG Xinjun , WEI Shaozhong .
Prognostic value of inflammatory and immune markers in resectable colorectal cancer
[J]. China Oncology, 2021, 31(9): 845-851.
|
[2] |
LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua .
Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
[J]. China Oncology, 2021, 31(8): 740-745.
|
[3] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[4] |
GONG Runze, HU Haiyan.
Clinical significance of CCL2 expression in osteosarcoma tissue
[J]. China Oncology, 2021, 31(6): 455-459.
|
[5] |
CHEN Guo , HAN Pengli , CHEN Keru , LI Mingchuang , ZHANG Qingsong , CHEN Zheng , DONG Hanhua , QIAN Yuejun , LÜ Jing .
Molecular mechanism of miR-19b-3p regulating apoptosis of medullary thyroid cancer cells by targeting MTUS1
[J]. China Oncology, 2021, 31(5): 390-396.
|
[6] |
PENG Zishan, KONG Hui, BAO Zhen, ZHAO Hongxing, LIU Xin, LU Shaohua.
Clinicopathological analysis of 83 cases of multifocal lung adenocarcinoma
[J]. China Oncology, 2021, 31(5): 408-418.
|
[7] |
XIAO Feng , XIAO Jingwen , SHAO Jianguo , CHEN Liyan , GU Chunyan .
The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis
[J]. China Oncology, 2021, 31(5): 419-427.
|
[8] |
NIU Na, LIN Yansong.
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
[J]. China Oncology, 2021, 31(5): 428-434.
|
[9] |
LIU Min , CHEN Tianliang , GUO Juan , YI Xue , GAO Hongquan , WU Jiacui , WANG Yuxiao .
Protein kinase Cβ Ⅱ promotes invasion of hepatocellular carcinoma by modulating autocrine of IL-6
[J]. China Oncology, 2021, 31(4): 268-276.
|
[10] |
ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang .
A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma
[J]. China Oncology, 2021, 31(4): 294-301.
|
[11] |
WANG Chunjian , NIE Gang , MAO Yan .
The role of TRIP6 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(3): 161-169.
|
[12] |
WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming .
Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma
[J]. China Oncology, 2021, 31(3): 212-220.
|
[13] |
YANG Liusong , ZHU Yingfeng , TANG Jianmin .
Ten cases of epithelioid glioblastoma and review of literature
[J]. China Oncology, 2021, 31(2): 114-120.
|
[14] |
DING Ping’an , ZHANG Zhidong , YANG Peigang , LIN Yecheng , TIAN Yuan , XU Xiaosheng , WU Juan , LIU Ying , GUO Honghai , LIU Yang , WANG Dong , TAN Bibo , LI Yong , ZHAO Qun .
Clinicopathological characteristics and prognostic analysis of leptomeningeal metastasis from gastric cancer
[J]. China Oncology, 2021, 31(2): 126-135.
|
[15] |
ZHOU Hongyu , LI Haoran , CHENG Xi , CHEN Lihua , YANG Yufei , CHANG Bin .
Clinical characteristics of 11 patients with small cell carcinoma of the ovary, hypercalcemic type and literature review
[J]. China Oncology, 2021, 31(2): 136-142.
|